Immediate Impact

56 standout
Sub-graph 1 of 24

Citing Papers

Traditional Chinese medicine in lung cancer treatment
2025 Standout
Thirty years of NRF2: advances and therapeutic challenges
2025 Standout
2 intermediate papers

Works of Dong‐Lin Chen being referenced

NFE2L2/KEAP1 Mutations Correlate with Higher Tumor Mutational Burden Value/PD-L1 Expression and Potentiate Improved Clinical Outcome with Immunotherapy
2020
Partial synthesis and biological evaluation of bisbenzylisoquinoline alkaloids derivatives: potential modulators of multidrug resistance in cancer
2012

Author Peers

Author Last Decade Papers Cites
Dong‐Lin Chen 342 268 76 76 39 538
Ning Li 210 121 149 48 42 536
Yuanwei Jia 326 148 107 35 38 553
Jun‐Tack Kwon 178 189 41 51 29 547
Chenxiao Shan 308 108 35 40 51 511
Daneng Wei 263 80 46 25 24 487
Bo‐Hua Zhong 205 72 95 86 59 569
Weijia Chen 325 83 60 18 60 594
Hyojung Kim 249 83 34 23 35 602
Marie‐Hélène Antoine 218 105 42 145 38 558
Azza M. Agha 148 80 74 16 29 608

All Works

Loading papers...

Rankless by CCL
2026